Episode Details
Back to EpisodesRyjunea Approved in the UK for Myopia
Published 6 months, 3 weeks ago
Description
Sydnexis receives another regulatory approval for its childhood myopia eye drop; Eli Lilly makes two major investments in ophthalmology; and Nanoscope reports new long-term data for its intravitreal optogenetic therapy for RP.
Learn more about your ad choices. Visit megaphone.fm/adchoices